Alpha Breaking
Alpha BreakingBack to Alpha Breaking
Alpha BreakingAlpha Breaking
Neutral Sentiment

EBV: Innovative Molecules Expands Virology Pipeline with Novel EBV Antiviral Program

Tuesday, June 16, 2026 at 7:01 AM ET
$EBV
EBV: Innovative Molecules Expands Virology Pipeline with Novel EBV Antiviral Program

Share this article

Spread the word on social media

Latest Updates

Jun 16, 7:52 AM

Innovative Molecules Expands Virology Pipeline with Novel EBV Antiviral Program

MUNICH, June 16, 2026 /PRNewswire/ -- Innovative Molecules GmbH ("IM"), a clinical-stage biopharmaceutical company focused on herpesvirus-mediated diseases, today announced the advancement of its virology pipeline with the addition of a novel Epstein-Barr Virus (EBV) antiviral program....

Source: PR Newswire
Jun 16, 7:46 AM

Innovative Molecules Expands Virology Pipeline with Novel EBV Antiviral Program

MUNICH, June 16, 2026 /PRNewswire/ -- Innovative Molecules GmbH ("IM"), a clinical-stage biopharmaceutical company focused on herpesvirus-mediated diseases, today announced the advancement of its virology pipeline with the addition of a novel Epstein-Barr Virus (EBV) antiviral program....

Source: PR Newswire

Sources

Trade this headline in Alpha Contests.

Free practice contests — earn Alpha Coins
Enter a Contest

Explore More

Stay Ahead of the Market

Get breaking news on trending finance topics delivered as they happen. We find the stories others miss.

More Breaking News

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.